Rorer International Cosmetics, Ltd. v. Halpern

502 F. Supp. 137, 1980 U.S. Dist. LEXIS 15142
CourtDistrict Court, E.D. Pennsylvania
DecidedOctober 1, 1980
DocketCiv. A. 79-1168
StatusPublished

This text of 502 F. Supp. 137 (Rorer International Cosmetics, Ltd. v. Halpern) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rorer International Cosmetics, Ltd. v. Halpern, 502 F. Supp. 137, 1980 U.S. Dist. LEXIS 15142 (E.D. Pa. 1980).

Opinion

MEMORANDUM

HUYETT, District Judge.

This is an action arising under section 10(b) (§ 10(b)) of the Securities Exchange Act of 1934 (the 1934 Act), regulations thereunder, and pendent claims under state blue sky laws. The complaint also states a breach of contract claim. Defendant has moved for summary judgment on all claims. The motion was extensively briefed by both sides, and oral argument was held. Because I can find no genuine issues of material fact on the record before me, and because defendant is entitled to summary judgment as a matter of law, defendant’s motion must be granted.

Plaintiff Rorer Group, Inc. (Rorer) is a public corporation headquartered in Ft. Washington, Pennsylvania. Plaintiff Rorer International Cosmetics, Ltd. (RICL) is or was a wholly-owned subsidiary of Rorer, engaged in the cosmetics business.

From his father’s death in 1971 until September 3,1976, defendant was the president and principal shareholder of Balenciaga Parfums, Inc. (Parfums), a New York Corporation. Balenciaga, S.A., a French concern founded by the late designer, Cristobal Balenciaga, owned the worldwide rights to products bearing the Balenciaga name, including fragrance products. Under certain agreements, collectively the North American Rights Agreement (NARA), entered into in 1958 and 1960 with defendant’s father, Parfums acquired the United States trademarks for Balenciaga fragrance products and was given the franchise to distribute Balenciaga fragrance products in North America.

On September 3, 1976, plaintiffs purchased Parfums. The acquisition took the form of cash payments for substantially all *139 the outstanding capital stock of Parfums, the bulk of which was owned or controlled by defendant. The purchase price was $1,500,000, of which $1,100,000 was paid to or set aside for the selling shareholders at closing, with the remaining $400,000 to be paid to defendant at the rate of $15,000 quarterly, pursuant to a consulting agreement.

After making the first seven payments to defendant, plaintiffs refused to pay anything further. This action followed. As elaborated by plaintiffs’ answers to interrogatories, plaintiffs’ claims were as follows:

1. Defendant fraudulently concealed from plaintiffs that Parfums, while under his control, created or marketed formulations of perfumes and other products not authorized by the NARA (the counterfeiting claim).

2. Defendant fraudulently concealed from plaintiffs that Parfums, while under his control, had failed to exert its best efforts to distribute Balenciaga products and to maximize their markets (the best efforts claim).

3. Defendant fraudulently misrepresented to plaintiffs that they were purchasing 100% of Parfum’s outstanding shares, when in fact the transfer did not include 20 shares originally issued in the name of Sol A. Rosenblatt (the Rosenblatt shares claim).

4. Defendant fraudulently concealed from Balenciaga, S.A. the true facts respecting the terms of plaintiffs’ acquisition of Parfums, despite the fact that under the NARA, Balenciaga, S.A. had right of first refusal on the disposition of its North American licensee (the first refusal claim).

5. Defendant, by engaging in the above misconduct, breached the consulting agreement (the contract claim).

At oral argument, counsel for plaintiffs withdrew the right of first refusal claim. He also abandoned the best efforts claim as a separate substantive claim, noting however that it was in reality a part of the counterfeiting claim. Thus I shall discuss the best efforts claim, the counterfeiting claim, the Rosenblatt shares claim, and the contract claim.

Turning first to what plaintiffs now consider the best efforts claim subsection of the counterfeiting claim, I note that it is undisputed on the record that plaintiffs had actual knowledge that Parfums, while under defendant’s control, had failed to exert its best efforts to distribute Balenciaga products and to maximize their markets. Exhibit 26 to defendant’s motion, an internal memorandum to plaintiff Rorer’s board of directors, states in part, “Balenciaga has not produced exceptional sales in the U. S. because the products have not been fully promoted. ...” Further, the affidavit of Mr. Peters, Rorer’s president during the period under consideration, states at paragraph 8 that Juan Ellacuria, president of Balenciaga S.A., told affiant “that Parfums had been undermining the Balenciaga trademark for years, and that the Halperns and Parfums had consistently refused to make a genuine effort to expand the sales of Balenciaga fragrances in the franchised territories.” Thus the record clearly shows that Balenciaga, S.A. considered Parfums in violation of the NARA due to failure to exert best efforts, and that plaintiffs knew that best efforts had indeed not been exerted. Plaintiffs have presented no record support whatsoever to the contrary. Thus there exists no genuine issue as to this matter. Defendants are entitled to summary judgment as a matter of law on the best efforts claim because, plaintiffs having had actual knowledge of this situation, defendants cannot be held liable for having concealed that information where the “total mix” of information available to the purchasers put them on actual notice of the problem. Smallwood v. Pearl Brewing Co., 489 F.2d 579, 606 (5th Cir.), cert. denied, 419 U.S. 873, 95 S.Ct. 134, 42 L.Ed.2d 113 (1974); Spielman v. General Host Corp., 402 F.Supp. 190 (S.D.N.Y.1975); Phillips v. Reynolds & Co., 294 F.Supp. 1249 (E.D.Pa.1969).

Defendant argues in regard to the counterfeiting claim that (1) plaintiffs were properly advised of the facts which Balenci *140 aga S.A. considered to constitute counterfeiting, and that (2) even if no such facts were communicated to plaintiffs, the omitted facts were not material to plaintiffs’ investment decision in that absence of counterfeiting was not relied upon by plaintiffs in making that decision. Plaintiffs have created a genuine issue as to whether they were actually advised of all of the facts underlying the counterfeiting claim through the exhibits to their memorandum in opposition to the motion. However, defendant is entitled to summary judgment as to this claim because the allegedly omitted information was not material to their investment decision, and the 1934 Act and the applicable SEC regulation require concealment of material information in order for such concealment to be actionable. See 15 U.S.C. § 78j(b); 17 C.F.R. § 240.10b-5. In this regard, defendant has presented considerable record support through deposition testimony of plaintiff Rorer’s president during the acquisition negotiations, Mr. Peters, deposition testimony and affidavits of plaintiff Rorer’s attorney for the acquisition, Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
502 F. Supp. 137, 1980 U.S. Dist. LEXIS 15142, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rorer-international-cosmetics-ltd-v-halpern-paed-1980.